ASLAN Pharmaceuticals Limited Skyrocketed
Wed, Feb 28, 2024 at 07:11 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) jumped higher at $0.7, representing a gain of 46.4%. On Wed, Feb 28, 2024, ASLN:NASDAQ touched a New 2-Week High of $0.7. From Wed, Feb 14, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- Vivani Medical Inc. Com (VANI:NASDAQ), 270.3%
- Envoy Med Inc Cl A (COCH:NASDAQ), 190.08%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 100.6%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 91.33%
- Movella Holdings Inc Com (MVLA:NASDAQ), 61.29%
- Bandwidth Inc. (BAND:NASDAQ), 51.77%
- Incannex Healthcare Limited (IXHL:NASDAQ), 48.58%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 46.44%
- ACM Research, Inc. (ACMR:NASDAQ), 40.8%